Chattem Concealed Carcinogen In Dexatrim, Suit Says
By Sean McLernon ( May 1, 2012, 1:55 PM EDT) -- Drugmaker Chattem Inc. was struck with a putative class action Friday in California federal court accusing the company of falsely marketing its over-the-counter Dexatrim-brand weight loss pills as safe and effective while actively concealing a cancer-causing chemical ingredient....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.